Better Ways to Predict Cervical Cancer Treatment Success
Combined Imaging and RNA Analyses to Develop Cervical Cancer Biomarkers
['FUNDING_R01'] · WASHINGTON UNIVERSITY · NIH-11111372
This research aims to find new ways to predict how well cervical cancer patients will respond to treatment by looking at imaging scans and genetic information from their tumors.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | WASHINGTON UNIVERSITY (nih funded) |
| Locations | 1 site (SAINT LOUIS, UNITED STATES) |
| Trial ID | NIH-11111372 on ClinicalTrials.gov |
What this research studies
Cervical cancer remains a significant health concern, and finding the best treatment for each patient can greatly improve their chances of survival. This project combines information from medical images, like CT scans, with detailed genetic data from tumor samples to understand how a tumor might react to treatment. By bringing these different types of information together, we hope to create more personalized treatment plans. This could help doctors know earlier if a treatment is working, allowing them to adjust care for the best possible outcome.
Who could benefit from this research
Good fit: This research is focused on understanding cervical cancer and treatment responses in patients with this condition.
Not a fit: Patients without cervical cancer would not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to more personalized and effective treatment strategies for cervical cancer patients, potentially improving their survival rates.
How similar studies have performed: Previous work by these researchers and others has shown promise using RNA and imaging as biomarkers for cancer, suggesting a foundation for this combined approach.
Where this research is happening
SAINT LOUIS, UNITED STATES
- WASHINGTON UNIVERSITY — SAINT LOUIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LI, HUA — WASHINGTON UNIVERSITY
- Study coordinator: LI, HUA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancer Patient, Cancer Treatment, Cancers